G Steiger

1.0k total citations
27 papers, 804 citations indexed

About

G Steiger is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, G Steiger has authored 27 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in G Steiger's work include Complement system in diseases (14 papers), Blood groups and transfusion (7 papers) and Hepatitis B Virus Studies (4 papers). G Steiger is often cited by papers focused on Complement system in diseases (14 papers), Blood groups and transfusion (7 papers) and Hepatitis B Virus Studies (4 papers). G Steiger collaborates with scholars based in Switzerland, France and United States. G Steiger's co-authors include Jürg A. Schifferli, Manuel Pascual, J P Paccaud, J.A. Schifferli, J Estreicher, A.G. Sjöholm, G. Hauptmann, Carina Danielsson, Nada Madi and J.-M. Dayer and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

G Steiger

27 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Steiger Switzerland 17 476 255 154 142 138 27 804
Frank J. Waxman United States 15 648 1.4× 321 1.3× 134 0.9× 118 0.8× 125 0.9× 25 970
Toshihiko Kaneshige Japan 17 411 0.9× 234 0.9× 196 1.3× 95 0.7× 113 0.8× 37 1.0k
Setsuya Naito Japan 18 523 1.1× 93 0.4× 274 1.8× 115 0.8× 46 0.3× 48 1.1k
Z Awdeh United States 8 448 0.9× 162 0.6× 157 1.0× 110 0.8× 40 0.3× 14 726
G. J. O’Neill United States 14 383 0.8× 214 0.8× 50 0.3× 206 1.5× 34 0.2× 21 850
Roger E Spitzer United States 15 445 0.9× 226 0.9× 42 0.3× 83 0.6× 55 0.4× 50 733
Judith Forristal United States 22 702 1.5× 376 1.5× 124 0.8× 134 0.9× 68 0.5× 32 1.1k
U Nydegger Switzerland 15 276 0.6× 378 1.5× 59 0.4× 75 0.5× 40 0.3× 40 763
John L. Abruzzo United States 15 235 0.5× 102 0.4× 324 2.1× 155 1.1× 74 0.5× 38 817
Rainald Zeuner Germany 15 468 1.0× 76 0.3× 260 1.7× 144 1.0× 34 0.2× 32 841

Countries citing papers authored by G Steiger

Since Specialization
Citations

This map shows the geographic impact of G Steiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Steiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Steiger more than expected).

Fields of papers citing papers by G Steiger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Steiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Steiger. The network helps show where G Steiger may publish in the future.

Co-authorship network of co-authors of G Steiger

This figure shows the co-authorship network connecting the top 25 collaborators of G Steiger. A scholar is included among the top collaborators of G Steiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Steiger. G Steiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pascual, Manuel, G Steiger, Salima Sadallah, et al.. (1994). Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes.. The Journal of Experimental Medicine. 179(3). 889–899. 74 indexed citations
2.
Pascual, Manuel, Carina Danielsson, G Steiger, & Jürg A. Schifferli. (1994). Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. European Journal of Immunology. 24(3). 702–708. 44 indexed citations
3.
Danielsson, Carina, Manuel Pascual, Lars E. French, G Steiger, & Jürg‐Alfred Schifferli. (1994). Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. European Journal of Immunology. 24(11). 2725–2731. 42 indexed citations
4.
Pascual, Manuel, H U Lutz, G Steiger, P Stammler, & Jürg A. Schifferli. (1993). Release of vesicles enriched in complement receptor 1 from human erythrocytes.. The Journal of Immunology. 151(1). 397–404. 61 indexed citations
5.
Pascual, Manuel, Michel A. Duchosal, G Steiger, et al.. (1993). Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.. The Journal of Immunology. 151(3). 1702–1711. 50 indexed citations
6.
Qi, Miao, G Steiger, & Jürg A. Schifferli. (1992). A calcium-dependent cryoglobulin IgM kappa/polyclonal IgG. The Journal of Immunology. 149(7). 2345–2351. 20 indexed citations
7.
Madi, Nada, G Steiger, J Estreicher, & Jürg A. Schifferli. (1992). Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS. The Journal of Immunology. 148(3). 723–728. 5 indexed citations
8.
Madi, Nada, J P Paccaud, G Steiger, & J.A. Schifferli. (1991). Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). Clinical & Experimental Immunology. 84(1). 9–15. 33 indexed citations
10.
Madi, Nada, G Steiger, J Estreicher, & Jürg A. Schifferli. (1991). Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE). Clinical & Experimental Immunology. 85(3). 373–378. 13 indexed citations
11.
Madi, Nada, J P Paccaud, G Steiger, & Jürg A. Schifferli. (1989). Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.. PubMed. 78(2). 201–6. 10 indexed citations
12.
Steiger, G, et al.. (1989). Reduced Immune Adherence of Antigen/Antibody Complexes Formed in the Presence of Complement in vivo and in vitro. PubMed. 6(6). 470–479. 7 indexed citations
13.
Schifferli, Jürg A., Philip Röth, G Steiger, J P Paccaud, & Mette Schmidt. (1988). Macro-prostatic acid phosphatase in a patient's serum.. Clinical Chemistry. 34(10). 2172–2174. 4 indexed citations
14.
Pascual, Manuel, G Steiger, J Estreicher, et al.. (1988). Metabolism of complement factor D in renal failure. Kidney International. 34(4). 529–536. 97 indexed citations
15.
Paccaud, J P, G Steiger, A.G. Sjöholm, Peter J. Spaeth, & Jürg A. Schifferli. (1987). Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.. PubMed. 69(2). 468–76. 22 indexed citations
16.
Schifferli, Jürg A., G Steiger, J P Paccaud, A.G. Sjöholm, & G. Hauptmann. (1986). Difference in the biological properties of the two forms of the fourth component of human complement (C4).. PubMed. 63(2). 473–7. 59 indexed citations
17.
Schifferli, Jürg A., G Steiger, Luigi L. Polla, Liliane Didierjean, & J.‐H. Saurat. (1985). Activation of the Alternative Pathway of Complement by Skin Immune Deposits. Journal of Investigative Dermatology. 85(5). 407–411. 11 indexed citations
18.
Schifferli, Jürg A., G Steiger, & M Schapira. (1985). The role of C1, C1-inactivator and C4 in modulating immune precipitation.. PubMed. 60(3). 605–12. 16 indexed citations
19.
Engler, Dennis, et al.. (1984). The Monodeiodination of Triiodothyronine and Reverse Triiodothyronine in Man: A Quantitative Evaluation of the Pathway by the Use of Turnover Rate Techniques*. The Journal of Clinical Endocrinology & Metabolism. 58(1). 49–61. 21 indexed citations
20.
Kistler, Peter M. & G Steiger. (1970). Human immunoglobulins for intravenous administration: preparation and properties.. PubMed. 4. 92–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026